Showing results (91-100 of 170) with videos related to
Sort By:
Pageof 17
The FEBS Journal|September 26, 2024
Crystal structure of Alzheimer's disease phospholipase D3 provides a molecular basis for understanding its normal and pathological functionsKenta Ishii, Stefan J Hermans, Maria Eleni Georgopoulou, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 17, 2013
Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin-mediated relaxation after in vivo serelaxin treatmentMaria Jelinic, Chen-Huei Leo, Emiel D Post Uiterweer, et al.Biophysical Reviews|March 28, 2022
Structural biology of cell surface receptors implicated in Alzheimer's diseaseStefan J Hermans, Tracy L Nero, Craig J Morton, et al.Inflammatory Bowel Diseases|August 4, 2021
Characterization of Skeletal Phenotype and Associated Mechanisms With Chronic Intestinal Inflammation in the Winnie Mouse Model of Spontaneous Chronic ColitisAhmed Al Saedi, Shilpa Sharma, Ebrahim Bani Hassan, et al.Bone|June 3, 2008
Model structure and control of bone remodeling: a theoretical studyPeter Pivonka, Jan Zimak, David W Smith, et al.Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivoLauren S Whyte, Erik Ryberg, Natalie A Sims, et al.Endocrinology|November 18, 2003
Gp130-mediated signaling is necessary for normal osteoblastic function in vivo and in vitroHong-In Shin, Paola Divieti, Natalie A Sims, et al.Journal of Theoretical Biology|September 29, 2009
Theoretical investigation of the role of the RANK-RANKL-OPG system in bone remodelingPeter Pivonka, Jan Zimak, David W Smith, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|December 17, 2011
Impaired vascular responses to relaxin in diet-induced overweight female ratsJoris van Drongelen, Arianne van Koppen, Jeanne Pertijs, et al.The Journal of Clinical Investigation|February 3, 2004
Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathwaysNatalie A Sims, Brendan J Jenkins, Julian M W Quinn, et al.Pageof 17